Glu(OtBu)-Val-Cit-PAB-OH is a non-cleavable ADC linker that has been used to synthesize protein-tubulysin conjugates.
Catalog Number | Size | Price | Quantity | |
---|---|---|---|---|
BADC-01753 | -- | $-- | Inquiry |
Glu(OtBu)-Val-Cit-PAB-OH is a peptide-based compound with significant applications in drug delivery systems, particularly in the design of prodrugs for targeted therapy. The structure includes key components such as glutamic acid (Glu), valine (Val), citrulline (Cit), and para-aminobenzoic acid (PAB), which are designed to optimize the pharmacokinetics and delivery of active pharmaceutical ingredients. The incorporation of an amino acid sequence like this allows for selective cleavage and release of the therapeutic agent at the target site, enhancing the precision of drug delivery and minimizing systemic toxicity. This feature is particularly valuable in cancer treatments, where targeted drug release can help overcome the challenges of conventional chemotherapy.
Another notable application of Glu(OtBu)-Val-Cit-PAB-OH is in the design of antibody-drug conjugates (ADCs) and other biomolecule-based therapeutic agents. The compound serves as a linker or part of a linker-payload system, enabling the attachment of cytotoxic agents to antibodies for targeted drug delivery. The citrulline residue in particular plays an important role in the stability and cleavage of the linker, ensuring the drug is released selectively at the site of action, such as within cancer cells or other diseased tissues. This makes Glu(OtBu)-Val-Cit-PAB-OH an important component in the development of novel ADCs for more effective and localized cancer treatments.
Additionally, Glu(OtBu)-Val-Cit-PAB-OH is being explored in the context of peptide-based vaccines and immunotherapies. The compound’s ability to serve as a flexible linker between immunomodulatory molecules or antigens enhances its utility in designing vaccines with better bioavailability and immune response activation. By strategically incorporating this peptide into vaccine formulations, it may be possible to improve the stability of the antigen, ensure controlled release, and promote a more targeted immune response, which is crucial in the treatment of infectious diseases and cancer immunotherapy.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.